Protea Biosciences Group Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Protea Biosciences Group Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7844
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Protea Biosciences Group Inc (Protea) is a biotechnology company that develops mass spectometry solutions. The company offers technology for identification, characterization, and quantitation of biologically-important molecules for pharmaceutical development, research, and diagnostic applications. Its products include functionalized pipette tips and plates, gel protein separation and recovery, protein sample preparation, amplus HPLC columns and mass spectrometry standards, among others. Protea’s services include bioanalytical services and mass spec imaging services. The company’s bioanalytical services include biomarker discovery, advanced proteomics and protein, biotherapeutic characterization and peptide quantitation, among others. It also provides label free imaging, translational, and drug and metabolite distribution. The company serves pharmaceutical, clinical, academic and industrial research. Protea is headquartered in Morgantown, West Virginia, the US.

Protea Biosciences Group Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Protea Biosciences Group Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Protea Biosciences Group Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Protea Biosciences Group Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Protea Biosciences Group Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Protea Biosciences Group Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Protea Biosciences Group Inc, Medical Equipment, Deal Details 11
Partnerships 11
Protea Biosciences Enters into Licensing Agreement with Yale University 11
Protea Biosciences Enters into Research Agreement with Vaccine and Immunotherapy Center 12
Protea Biosciences Enters into Agreement with Massachusetts General Hospital 13
Protea Biosciences Extends Partnership with Protein Metrics 14
Protea Biosciences Enters into Agreement with Agilent Technologies 15
Protea Biosciences Enters into Agreement with InSphero for 3D Technologies 16
Protea Biosciences Enters Into Research Agreement With Virginia Commonwealth University For Molecular Imaging Techniques 17
Waters Enters Into Co-Marketing Agreement With Protea Biosciences Group For LASEI DP-1000 18
Equity Offering 19
Protea Biosciences Files Registration Statement to Raise up to USD17.3 Million in Public Offering of Shares 19
Protea Biosciences Group Raises USD0.6 Million in Private Placement 20
Protea Biosciences to Raise Funds through Public Offering of Shares 21
Protea Biosciences Raises USD0.98 Million in Public Offering of Units 22
Protea Biosciences Raises USD2.53 Million in Public Offering of Units 23
Protea Biosciences Group Completes Private Placement Of Shares For US$0.7 Million 24
Protea Biosciences Completes Private Placement Of Shares For US$0.5 Million 25
Debt Offering 26
Protea Biosciences Raises USD0.1 Million in Private Placement of Debentures 26
Protea Biosciences Raises USD1.61 Million in Private Placement of Debentures 27
Protea Biosciences Raises USD2 Million in Private Placement of Debentures 28
Protea Biosciences Group Completes Private Placement Of Debt Securities For US$0.3 Million 29
Asset Transactions 30
Purdue University Acquires LAESI DP-1000 Instrument System from Protea Biosciences 30
Princeton University Acquires LAESI DP-1000 Instrument System from Protea Biosciences 31
United States Department of Agriculture Acquires Laesi DP-1000 from Protea Biosciences 32
Protea Biosciences Group Inc – Key Competitors 33
Protea Biosciences Group Inc – Key Employees 34
Protea Biosciences Group Inc – Locations And Subsidiaries 35
Head Office 35
Other Locations & Subsidiaries 35
Recent Developments 36
Financial Announcements 36
Apr 18, 2017: Protea Announces 2016 Year End Results 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
Protea Biosciences Group Inc, Medical Equipment, Key Facts 2
Protea Biosciences Group Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Protea Biosciences Group Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Protea Biosciences Group Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Protea Biosciences Group Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Protea Biosciences Group Inc, Deals By Market, 2012 to YTD 2018 8
Protea Biosciences Group Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Protea Biosciences Enters into Licensing Agreement with Yale University 11
Protea Biosciences Enters into Research Agreement with Vaccine and Immunotherapy Center 12
Protea Biosciences Enters into Agreement with Massachusetts General Hospital 13
Protea Biosciences Extends Partnership with Protein Metrics 14
Protea Biosciences Enters into Agreement with Agilent Technologies 15
Protea Biosciences Enters into Agreement with InSphero for 3D Technologies 16
Protea Biosciences Enters Into Research Agreement With Virginia Commonwealth University For Molecular Imaging Techniques 17
Waters Enters Into Co-Marketing Agreement With Protea Biosciences Group For LASEI DP-1000 18
Protea Biosciences Files Registration Statement to Raise up to USD17.3 Million in Public Offering of Shares 19
Protea Biosciences Group Raises USD0.6 Million in Private Placement 20
Protea Biosciences to Raise Funds through Public Offering of Shares 21
Protea Biosciences Raises USD0.98 Million in Public Offering of Units 22
Protea Biosciences Raises USD2.53 Million in Public Offering of Units 23
Protea Biosciences Group Completes Private Placement Of Shares For US$0.7 Million 24
Protea Biosciences Completes Private Placement Of Shares For US$0.5 Million 25
Protea Biosciences Raises USD0.1 Million in Private Placement of Debentures 26
Protea Biosciences Raises USD1.61 Million in Private Placement of Debentures 27
Protea Biosciences Raises USD2 Million in Private Placement of Debentures 28
Protea Biosciences Group Completes Private Placement Of Debt Securities For US$0.3 Million 29
Purdue University Acquires LAESI DP-1000 Instrument System from Protea Biosciences 30
Princeton University Acquires LAESI DP-1000 Instrument System from Protea Biosciences 31
United States Department of Agriculture Acquires Laesi DP-1000 from Protea Biosciences 32
Protea Biosciences Group Inc, Key Competitors 33
Protea Biosciences Group Inc, Key Employees 34
Protea Biosciences Group Inc, Subsidiaries 35

List of Figures
Protea Biosciences Group Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Protea Biosciences Group Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Protea Biosciences Group Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Protea Biosciences Group Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Protea Biosciences Group Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Protea Biosciences Group Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Protea Biosciences Group Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Protea Biosciences Group Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Protea Biosciences Group Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Christus Health:企業の戦略的SWOT分析
    Christus Health - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Bayer AG (BAYN):製薬・医療:M&Aディール及び事業提携情報
    Summary Bayer AG (Bayer) carries out the research, development, production and commercialization of products for human and animal health care, and agriculture. It provides medicines for cardiovascular diseases, women’s health, cancer, hematology, ophthalmology and other indications. The company's pr …
  • Novaliq GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Novaliq GmbH (Novaliq) is a drug delivery company that develops pharmaceutical formulations. The company develops novel ophthalmic and dermatological products, and solutions for organ preservation based on the physicochemical properties of semifluorinated alkanes. It offers NovaTears, a pres …
  • Grupo Aval Acciones Y Valores Sa:企業の戦略・SWOT・財務分析
    Grupo Aval Acciones Y Valores Sa - Strategy, SWOT and Corporate Finance Report Summary Grupo Aval Acciones Y Valores Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Orca Gold Inc (ORG):企業の財務・戦略的SWOT分析
    Summary Orca Gold Inc (Orca Gold), formerly Canaco Resources Inc, subsidiary of Pinetree Capital Ltd, is a gold exploration company. The company's activities include acquisition, exploration and development of mineral properties in North and West Africa. It holds interests in The Block 14 gold proje …
  • Telephone and Data Systems, Inc.:企業の戦略・SWOT・財務情報
    Telephone and Data Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Telephone and Data Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Steinhoff International Holdings NV (SNH):企業の財務・戦略的SWOT分析
    Steinhoff International Holdings NV (SNH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Rolta India Ltd (ROLTA):企業の財務・戦略的SWOT分析
    Rolta India Ltd (ROLTA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Taiga Building Products Ltd (TBL):企業の財務・戦略的SWOT分析
    Taiga Building Products Ltd (TBL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Viscofan, S.A.:企業の戦略・SWOT・財務情報
    Viscofan, S.A. - Strategy, SWOT and Corporate Finance Report Summary Viscofan, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Sage Therapeutics Inc (SAGE):企業の財務・戦略的SWOT分析
    Sage Therapeutics Inc (SAGE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Oneok Inc (OKE):企業の財務・戦略的SWOT分析
    Oneok Inc (OKE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Algonquin Power & Utilities Corp (AQN):電力:M&Aディール及び事業提携情報
    Summary Algonquin Power & Utilities Corp. (APUC) generates, transmits and distributes energy. It generates electricity through non-regulated renewable and clean energy and thermal generation facilities across North America. The company distributes electricity in California and New Hampshire; natural …
  • Noni B Ltd (NBL):企業の財務・戦略的SWOT分析
    Noni B Ltd (NBL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Eni S.p.A:企業の戦略・SWOT・財務情報
    Eni S.p.A - Strategy, SWOT and Corporate Finance Report Summary Eni S.p.A - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • NorthWestern Corporation:発電所・企業SWOT分析
    NorthWestern Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key empl …
  • GI Dynamics Inc (GID):医療機器:M&Aディール及び事業提携情報
    Summary GI Dynamics Inc (GI Dynamics) is a clinical stage medical device company that develops and commercializes endoscopy instruments. The company develops EndoBarrier, a device to treat type 2 diabetes and obesity, which is delivered endoscopically. The device imitates the mechanisms of metabolic …
  • ASGN Inc (ASGN):企業の財務・戦略的SWOT分析
    Summary ASGN Inc (ASGN), formerly known as On Assignment Inc, provides professionals for technology, life sciences, and creative sectors. It offers qualified professionals and human capital services. The company’s cybercoders recruits professionals for engineering, technology, sales, executive, fina …
  • MEDITE Cancer Diagnostics Inc (MDIT):医療機器:M&Aディール及び事業提携情報
    Summary MEDITE Cancer Diagnostics Inc (MEDITE), formerly CytoCore, Inc., specializes in the development, engineering, manufacturing and marketing of premium medical devices and consumables for detection, risk assessment and diagnosis of cancer and related diseases. Its major devices include ultrason …
  • Seoul National University Hospital:企業の戦略的SWOT分析
    Seoul National University Hospital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆